SEPOY.net
No Result
View All Result
Saturday, July 19, 2025
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

Amyloid-PET scanning has misled the FDA into granting approval for Aduhelm

Nicholas by Nicholas
November 16, 2022
in Health
0
Amyloid-PET scanning has misled the FDA into granting approval for Aduhelm

Last year, the FDA gave accelerated approval of the antibody aducanumab (marketed as Aduhelm by Biogen) for the treatment of Alzheimer’s disease. The approval was based solely on a presumed reduction in the amount of the protein “amyloid” in the brain as assessed by amyloid-PET scans and without evidence of significant clinical effect.

READ ALSO

Hypertensive disorders in pregnancy linked to lower breastfeeding rates

Study reveals complex patterns of burden and survival among people with digestive system cancers in China

In a Commentary published in the Journal of Alzheimer’s Disease, authors Poul F. Høilund-Carlsen, Mona-Elisabeth Revheim, Abass Alavi , Nagichettiar Satyamurthy, and Jorge R. Barrio have detailed their views questioning the amyloid hypothesis that has dominated Alzheimer research and treatment trials for 30 years. In particular they question the use of amyloid-PET scanning, an imaging procedure that has been used to show whether new therapies are able to reduce cerebral amyloid deposits as this is assumed to inhibit the development of Alzheimer’s disease. They contend that this very finding contributed to the FDA’s approval of Aduhelm contrary to its own independent expert panel which looked in vain for evidence of a favorable clinical effect.

We believe this kind of PET scanning is questionable and has misled the FDA into making a decision contrary to the agency’s foremost mission to “protect and promote the public health. Background for the approval is a never proven ‘amyloid hypothesis’ suggesting that Alzheimer’s disease is caused by cerebral amyloid deposits. Instead of reducing the amount of amyloid in the brain, we fear that Aduhelm and similar drugs cause increased brain damage.”

Abass Alavi, MD, Author, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA

Dr. Alavi continued, “In addition to our concerns, we suspect that the amyloid PET scans performed are not reflecting amyloid removal, but rather are indicative of increased therapy-induced brain damage. We, therefore, strongly recommend that the FDA puts its Aduhelm approval on hold and requires thorough investigation of our presumption before taking a position on any further Alzheimer immunotherapy applications.”

Source:

Journal reference:

Høilund-Carlsen, P.F.., et al. (2022) Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials. Journal of Alzheimer’s Disease. doi.org/10.3233/JAD-220841.

Tags: Alzheimer's DiseaseAntibodyBiogenBrainProtein

Related Posts

Hypertensive disorders in pregnancy linked to lower breastfeeding rates
Health

Hypertensive disorders in pregnancy linked to lower breastfeeding rates

July 19, 2025
Study reveals complex patterns of burden and survival among people with digestive system cancers in China
Health

Study reveals complex patterns of burden and survival among people with digestive system cancers in China

July 18, 2025
Cuproptosis offers new hope for treating inflammatory bowel disease and colorectal cancer
Health

Cuproptosis offers new hope for treating inflammatory bowel disease and colorectal cancer

July 18, 2025
New mRNA vaccine strategy awakens immune system to fight cancer
Health

New mRNA vaccine strategy awakens immune system to fight cancer

July 18, 2025
Acorn-based coffee boosts antioxidants with minimal health risk
Health

Acorn-based coffee boosts antioxidants with minimal health risk

July 18, 2025
PAR1 protein found to boost lung fluid drainage during injury
Health

PAR1 protein found to boost lung fluid drainage during injury

July 18, 2025
Next Post
International match in the live ticker: Oman against Germany

International match in the live ticker: Oman against Germany

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: hello@sepoy.net

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Where’s niagara falls slot the newest Silver Slot the real deal Money Gamble Online and Get Your Bonus Today
  • Directory of The mugshot madness slot games 23 PA Online casinos The newest to own Jul 2025
  • Scrolls from Ra Demonstration Pokies Gamble Totally free Slot machine

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net